Clinics in Dermatology
Volume 24, Issue 4 , Pages 266-275 , July 2006

Dermatologic manifestations of hypopituitarism

References 

  1. Melmed S, Kleinberg D. Anterior pituitary. In:  Larson PR,  Kronberg HM,  Melmed S,  Polonsky KS editor. Williams textbook of endocrinology. 10th ed. Philadelphia: Elsevier Science; 2003;p. 177–280
  2. Toogood AA. Endocrine consequences of brain irradiation. Growth Horm IGF Res. 2004;14:S118–S124
  3. Darzy KH, Shalet SM. Radiation-induced growth hormone deficiency. Horm Res. 2003;59:1–11
  4. Kelly DF, Gpnzalo IT, Cohan P, et al. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg. 2000;743–752
  5. Aimaretti G, Ambrosio MR, Di Somma C, et al. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf). 2004;61:320–326
  6. Aron DC, Findling JW, Tyrrell JB. Hypothalamus and pituitary gland. In:  Greenspan FS,  Gardner DG editor. Basic and clinical endocrinology. 7th ed. New York: Lange; 2004;p. 106–175
  7. Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res. 2000;54:230–242
  8. Grando SA. Physiology of endocrine skin interrelations. J Am Acad Dermatol. 1993;28:981–992
  9. Slominski A, Wortsman J. Neuroendocrinology of the skin. Endocr Rev. 2000;21:457–487
  10. Bonert-Herman V, Melmed S. Growth hormone. In:  Melmed S editors. Pituitary. 2nd ed. Malden: Blackwell; 2002;p. 79–118
  11. Rosen M, Cedars MI. Female reproductive endocrinology and infertility. In:  Greenspan FS,  Gardner DG editor. Basic and clinical endocrinology. 7th ed. New York: Lange; 2004;p. 511–563
  12. Bichet DG. The posterior pituitary. In:  Melmed S editors. Pituitary. 2nd ed. Malden: Blackwell; 2002;p. 279–314
  13. Carlson HE. The pituitary gland in pregnancy and the puerperium. In:  Melmed S editors. Pituitary. 2nd ed. Malden: Blackwell; 2002;p. 633
  14. Sheehan HL, Davis JC. In: Post-partum hypopituitarism. Springfield: Charles C. Thomas; 1982;p. 222–229
  15. Aboud CF. Anterior pituitary failure. In:  Melmed S editors. Pituitary. 2nd ed. Malden: Blackwell; 2002;p. 350–351
  16. Cummings GE, Merriam GR. Growth hormone therapy in adults. Annu Rev Med. 2003;53:513–533
  17. Larson PR, Davies TF. Hypothyroidism and thyroiditis. In:  Larson PR,  Kronberg HM,  Mnelmed S,  Polonsky KS editor. Williams textbook of endocrinology. 10th ed. Philadelphia: Elsevier Science; 2003;p. 423–455
  18. Jabbour SA, Miller JL. Endocrinopathies and the skin. Int J Dermatol. 2000;39:88–99
  19. Rosenberg RM, Isseroff RR, Ziboh VA, Huntley AC. Abnormal lipogenesis in thyroid hormone–deficient epidermis. J Invest Dermatol. 1986;86:244–248
  20. Leonhardt JM, Heymann WR. Thyroid disease and the skin. Dermatol Clin. 2002;20:473–481
  21. Randall VA, Hibberts NA, Thornton MJ, et al. The hair follicle: a paradoxical androgen target organ. Horm Res. 2000;54:243–250
  22. Feingold KR, Elias PM. Endocrine-skin interactions. Cutaneous manifestations of pituitary disease, thyroid disease, calcium disorders, and diabetes. J Am Acad Dermatol. 1987;17:921–940
  23. Braunstein GD. Androgen deficiency in women. In:  Carr BR,  Blackwell RE,  Azziz R editor. Essential reproductive medicine. New York: McGraw-Hill; 2005;p. 683–702
  24. Paus R. Does prolactin play a role in skin biology and pathology?. Med Hypotheses. 1991;36:33–42
  25. Foitzik K, Krause K, Nixon AJ, et al. Prolactin and its receptor are expressed in murine hair follicle epithelium, show hair cycle–dependent expression, and induce catagen. Am J Pathol. 2003;162:1611–1621
  26. Blum I, Leiba S. Increased hair loss as a side effect of bromocriptine treatment. N Engl J Med. 1980;303:1418
  27. Thiboutot DM. Clinical review 74: dermatological manifestations of endocrine disorders. J Clin Endocrinol Metab. 1995;80:3082–3087
  28. Safer JD, Crawford TM, Holick MF. A role for thyroid hormone in wound healing through keratin gene expression. Endocrinology. 2004;145:2357–2361
  29. Sator PG, Schmidt JB, Rabe T, Zouboulis CC. Skin aging and sex hormones in women—clinical perspectives for intervention by hormone replacement therapy. Exp Dermatol. 2004;13:36–40
  30. Phillips TJ, Demircay Z, Sahu M. Hormonal effects on skin aging. Clin Geriatr Med. 2001;17:661–672
  31. Schneider JB, Norman RA. Cutaneous manifestations of endocrine-metabolic disease and nutritional deficiency in the elderly. Dermatol Clin. 2004;22:23–31
  32. Lange M, Thulesen J, Feldt-Rasmussen U, et al. Skin morphological changes in growth hormone deficiency and acromegaly. Eur J Endocrinol. 2001;145:147–153
  33. Abramovici A, Josefsberg Z, Mimouni M, et al. Histopathological features of the skin in hypopituitarism and Laron-type dwarfism. Isr J Med Sci. 1983;19:515–519
  34. McGee S, Abernethy WB, Simel DL. The rational clinical examination. Is this patient hypovolemic?. JAMA. 1999;281:1022–1029
  35. Barkan A, Glantz I. Calcification of auricular cartilages in patients with hypopituitarism. J Clin Endocrinol Metab. 1982;55:354–357
  36. Slominski A, Wortsman J, Luger T, Paus R, Salomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80:979–1020
  37. Kauser S, Thody AJ, Schallreuter KU, et al. A fully functional proopiomelanocortin/melanocortin-1 receptor system regulates the differentiation of human scalp hair follicle melanocytes. Endocrinology. 2005;146:532–543
  38. Thody AJ, Graham A. Does alpha-MSH have a role in regulating skin pigmentation in humans?. Pigment Cell Res. 1998;11:265–274
  39. Vaudry H, Chartrel N, Desrues L, et al. The pituitary-skin connection in amphibians. Reciprocal regulation of melanotrope cells and dermal melanocytes. Ann N Y Acad Sci. 1999;885:41–56
  40. Vazquez-Martinez R, Peinado JR, Gonzalez De Aguilar JL, et al. Melanotrope cell plasticity: a key mechanism for the physiological adaptation to background color changes. Endocrinology. 2001;142:3060–3067
  41. Oakes SR, Haynes KM, Waters MJ, et al. Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab. 1992;75:1368–1373
  42. Juul A, Hjortskov N, Jepsen LT, et al. Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients. J Clin Endocrinol Metab. 1995;80:3335–3340
  43. Juul A, Behrenscheer A, Tims T, et al. Impaired thermoregulation in adults with growth hormone deficiency during heat exposure and exercise. Clin Endocrinol (Oxf). 1993;38:237–244
  44. Harrison BJ, Kumar S, Read GF, et al. Hidradenitis suppurativa: evidence for an endocrine abnormality. Br J Surg. 1985;72:1002–1004
  45. Matsuoka LY, Wortsman J, Gavin JR, Goldman J. Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med. 1987;83:719–725
  46. Lavalle C, Loyo E, Paniagua R, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol. 1987;2:268–272
  47. Robertson MT. Prolactin, human nutrition and evolution, and the relation to cystic fibrosis. Med Hypotheses. 1989;29:87–99
  48. De Mello-Coelho V, Savino W, Postel-Vinay MC, Dardenne M. Role of prolactin and growth hormone on thymus physiology. Dev Immunol. 1998;6:317–322
  49. Ogueta S, Munoz J, Obregon E, et al. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow–derived mesenchymal stem cells. Mol Cell Endocrinol. 2002;25:51–63
  50. Taussig LM, Braunstein GD. Effects of vasopressin on sweat rate and composition in patients with diabetes insipidus and normal controls. J Invest Dermatol. 1973;60:197–202
  51. Shimizu H, Obi T, Miyajima H. Anhidrosis: an unusual presentation of diabetes insipidus. Neurology. 1997;49:1708–1710
  52. Ring A, Mork AC. Electrophysiological responses to oxytocin and ATP in monolayers of a human sweat gland cell line. Biochem Biophys Res Commun. 1997;234:30–34
  53. Christianson HB. Cutaneous manifestations of hypothyroidism including purpura and ecchymoses. Cutis. 1976;17:45–52
  54. Levin NA, Greer KE. Cutaneous manifestations of endocrine disorders. Dermatol Nurs. 2001;13:185–202
  55. Carlson HE. The pituitary gland in systemic disorders. In:  Melmed S editors. Pituitary. 2nd ed. Malden: Blackwell; 2002;p. 613–627
  56. Arafah BM. Medical management of hypopituitarism in patients with pituitary adenomas. Pituitary. 2002;5:109–117
  57. Rhoden EL, Morgentaler A. Medical progress: risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med. 2004;350:482–492
  58. In:  Ezzat S editors. The pituitary patient resource guide. 3rd ed. Thousand Oaks, CA: Pituitary Network Association; 2005;

PII: S0738-081X(06)00054-X

doi: 10.1016/j.clindermatol.2006.04.014

Clinics in Dermatology
Volume 24, Issue 4 , Pages 266-275 , July 2006

Article Tools

* Image Usage & Resolution